NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

Description

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccines, Free Full-Text

Controlled Human Infection Models To Accelerate Vaccine

PDF) Vaccines Against COVID-19

Controlled Human Infection Models To Accelerate Vaccine

Intestinal helminth infection impairs oral and parenteral vaccine

Controlled Human Infection Models To Accelerate Vaccine

Frontiers Reduced immunogenicity of a live Salmonella enterica

Global Innovations (International Cooperation

Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for

News - VaccineNation

Bioengineering, Free Full-Text

Adjuvant Development Program NIAID: National Institute of

PDF) Reduced immunogenicity of a live Salmonella enterica serovar

Vaccine Adjuvant Discovery and Mechanistic Research

$ 18.00USD
Score 4.8(794)
In stock
Continue to book